ConductScience.org, home

Paper41007388

Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse.

Schifano F and 6 others. Biology (Basel), 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse. Papers, record 41007388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007388

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse.
PubMed
Journal
Biology (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.88, provisional
iCite
Revised in PubMed
2025-09-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schifano FFabriziohttps://orcid.org/0000-0002-4178-5401
2Bonaccorso SStefania
3Arillotta DDavidehttps://orcid.org/0000-0002-8843-0595
4Corkery JMJohn Martinhttps://orcid.org/0000-0002-3849-817X
5Floresta GGiuseppehttps://orcid.org/0000-0002-0668-1260
6Papanti Pelletier GDGabriele Duccio
7Guirguis AAmirahttps://orcid.org/0000-0001-8255-0660

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137533709On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective.Front Psychol2023https://conductscience.org/library/papers/37533709PubMed
232525422Cognitive Enhancing Drugs in Sport: Current and Future Concerns.Subst Use Misuse2020https://conductscience.org/library/papers/32525422PubMed
314600801AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).Naunyn Schmiedebergs Arch Pharmacol2003https://conductscience.org/library/papers/14600801PubMed
432297564Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a survey.J Addict Dis2020https://conductscience.org/library/papers/32297564PubMed
539503411Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.J Psychoactive Drugs2026https://conductscience.org/library/papers/39503411PubMed
640507904In Vivo Neuroprotective Effects of Alpinetin Against Experimental Ischemic Stroke Damage Through Antioxidant and Anti-Inflammatory Mechanisms.Int J Mol Sci2025https://conductscience.org/library/papers/40507904PubMed
740176115Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future.Transl Neurodegener2025https://conductscience.org/library/papers/40176115PubMed
837497241Editorial: Dopaminergic control of experience encoding, memory and cognition.Front Behav Neurosci2023https://conductscience.org/library/papers/37497241PubMed
925831025Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.J Enzyme Inhib Med Chem2016https://conductscience.org/library/papers/25831025PubMed
1011031090Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury.Exp Neurol2000https://conductscience.org/library/papers/11031090PubMed
1131287972What is cognition?Curr Biol2019https://conductscience.org/library/papers/31287972PubMed
1238280630Microdosing Psychedelics: Current Evidence From Controlled Studies.Biol Psychiatry Cogn Neurosci Neuroimaging2024https://conductscience.org/library/papers/38280630PubMed
1335366192Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.Drugs2022https://conductscience.org/library/papers/35366192PubMed
1439009578Inter-individual variability in neural response to low doses of LSD.Transl Psychiatry2024https://conductscience.org/library/papers/39009578PubMed
1526889810Dopamine Does Double Duty in Motivating Cognitive Effort.Neuron2016https://conductscience.org/library/papers/26889810PubMed
1628238510Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.Bioorg Med Chem2017https://conductscience.org/library/papers/28238510PubMed
1730200181Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.Molecules2018https://conductscience.org/library/papers/30200181PubMed
1836284231Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity.Neuropsychopharmacology2023https://conductscience.org/library/papers/36284231PubMed
192694231Nootropic drugs and brain cholinergic mechanisms.Prog Neuropsychopharmacol Biol Psychiatry1989https://conductscience.org/library/papers/2694231PubMed
2034978226Plant-derived nootropics and human cognition: A systematic review.Crit Rev Food Sci Nutr2023https://conductscience.org/library/papers/34978226PubMed

See all 88 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42587263Protective role of hemokinin-1 against age-dependent spatial memory and attention decline in mice.Geroscience2026https://conductscience.org/library/papers/42587263PubMed
42515793Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515793PubMed
42246992[Performance-related substance use in everyday life and work].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz2026https://conductscience.org/library/papers/42246992PubMed
42129301Prevalence and predictors of natural nootropic supplement use among medical and pharmacy students: a single-institution cross-sectional study.Sci Rep2026https://conductscience.org/library/papers/42129301PubMed
42079329The Role of Nootropic Supplements in Sports: Enhancing Cognitive and Physical Performance Simultaneously.Food Sci Nutr2026https://conductscience.org/library/papers/42079329PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007388

GET https://conductscience.org/api/papers/v1/41007388/references?page=2